Thymosin Alpha-1 dosing calculator
1 mg = 1000 mcg.
0.200 mL · 5,000 mcg/mL
- Doses per vial
- 10
- Per unit
- 50 mcg
- One vial lasts
- 10 days at 1/day
Your draw
www.undergroundbiohacking.com · For tracking and calculation purposes only. Not medical advice.
For tracking and calculation purposes only. Not medical advice. Based on a standard U-100 insulin syringe.
<iframe src="https://www.undergroundbiohacking.com/tools/embed/dosing-calculator?mg=10&ml=2&dose=1000&unit=mcg&syr=0.3&c=thymosin-alpha-1" width="480" height="560" style="border:0" title="Thymosin Alpha-1 Dosing Calculator"></iframe>Share this article
How the units are worked out
Your vial holds a fixed amount of peptide. The water you add sets the concentration (how much peptide sits in each millilitre). The concentration then decides how much liquid carries your dose.
Three steps, in order:
- Concentration (mcg/mL) = peptide in the vial (mcg) divided by water added (mL).
- Volume (mL) = your dose (mcg) divided by the concentration (mcg/mL).
- Units to draw = volume (mL) multiplied by 100.
That last step is the syringe, not the peptide. A U-100 insulin syringe is marked so 100 units hold 1 mL, so 0.1 mL reads as 10 units.
A worked example
These are the numbers in the calculator above, worked through: 10 mg + 2 mL = 5,000 mcg/mL. 1000 mcg = 0.20 mL = 20 units on a 0.3 mL syringe.
Change any number in the tool and this line changes with it. The link in your address bar carries the numbers, so you can save it or send it to yourself.
Water and units at a glance
The same dose of Thymosin Alpha-1 at different mixes. Every row opens the calculator on that mix.
| Vial | Water | Concentration | Units to draw |
|---|---|---|---|
| 10 mg | 1 mL | 10,000 mcg/mL | 10 units |
| 10 mg | 2 mL | 5,000 mcg/mL | 20 units |
| 10 mg | 3 mL | 3,333 mcg/mL | 30 units |
| 10 mg | 5 mL | 2,000 mcg/mL | 50 units |
Pre-filled numbers are the most-used setups reported by users of public calculators (WPA dosing data, Aug 2026). Not a recommendation.
Mixing and storage
Run the water down the inside wall of the vial and let the powder dissolve on its own. Never shake it. Label the vial with the compound, the total mass, the water you added, the concentration and the date. A sealed freeze-dried vial keeps 12 to 24 months in the fridge at 2 to 8°C. Once mixed with preserved water, such as bacteriostatic water, that drops to roughly 28 days refrigerated. Keep it at the back of the fridge, away from light and away from the door's temperature swings.
Other compounds
- BPC-157 calculator
- TB-500 calculator
- Ipamorelin calculator
- CJC-1295 calculator
- GHK-Cu calculator
- AOD-9604 calculator
- DSIP calculator
- Kisspeptin-10 calculator
- KPV calculator
- MOTS-c calculator
- Semaglutide calculator
- Tirzepatide calculator
- Retatrutide calculator
- BPC-157 + TB-500 calculator
- CJC-1295 + Ipamorelin calculator
Questions
Does thymosin alpha-1 actually work?
Is it approved as a medicine anywhere?
Can I get it legally in the United States?
Will it boost my immune system if I am healthy?
What did the COVID-19 research actually show?
What should I ask a doctor about it?
References
- 01Wu J, et al. (2013). The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial. Critical Care. PMID: 23327199. DOI: 10.1186/cc11932.
- 02Gu B, et al. (2025). Efficacy of thymosin α1 for sepsis: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Cellular and Infection Microbiology. PMID: 40969554. DOI: 10.3389/fcimb.2025.1673959.
- 03Yang YF, et al. (2007). Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: a meta-analysis. Antiviral Research. PMID: 18078676. DOI: 10.1016/j.antiviral.2007.10.014.
- 04Peng D, et al. (2020). The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis. BMC Gastroenterology. PMID: 33076834. DOI: 10.1186/s12876-020-01477-8.
- 05Soeroto AY, et al. (2023). The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regression. Inflammopharmacology. PMID: 37845598. DOI: 10.1007/s10787-023-01354-2.
- 06Carraro G, et al. (2011). Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study. Vaccine. PMID: 22178096. DOI: 10.1016/j.vaccine.2011.12.014.
- 07Guo CL, et al. (2021). Impact of thymosin α1 as an immunomodulatory therapy on long-term survival of non-small cell lung cancer patients after R0 resection: a propensity score-matched analysis. Chinese Medical Journal. PMID: 34732663. DOI: 10.1097/CM9.0000000000001819.
- 08Iino S, et al. (2005). The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial. Journal of Viral Hepatitis. PMID: 15850471. DOI: 10.1111/j.1365-2893.2005.00633.x.
- 09Wu J, et al. (2025). The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial. BMJ. PMID: 39814420. DOI: 10.1136/bmj-2024-082583.
- 10Liu J, et al. (2021). Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study. Frontiers in Immunology. PMID: 34408744. DOI: 10.3389/fimmu.2021.673693.
By Chris Hallewell, Founder, Underground Biohacking
Last reviewed
The numbers here describe your own vial. They are not medical advice and not a dose suggestion. Confirm your protocol with a qualified clinician.
The full Thymosin Alpha-1 page
What it is, what the research says, and how people use it.
Running a full cycle?
Put every compound, dose and date in one plan you can save.
